The Financial Chessboard: Bank of Montreal's Calculated Retreat from Ally

A Resounding Nod: Marketing's Finest Crowned at the 2025 CMA Awards

The Pharma Gambit: Why Pfizer Might Just Snatch Metsara from Novo's Grasp

Beyond the Balance Sheet: Canada's Big Banks Confront Their Digital Carbon Footprint

Pfizer's Pivotal Leap: BMO Analyst Seigerman Declares Bullish Outlook on Long-Awaited Obesity Market Entry via Metsara Deal

Central Banks' Foggy Path: Belski Warns Against Rate Cut Euphoria

Navigating 2025: Expert Insights from Nancy Tengler and Brian Belski on Market Outlook and Investment Strategies